---
title: 慈善机构设立基金投资脊髓损伤公司
date: 2024-06-08T13:00:29.923Z
description: Launch highlights growth of venture philanthropy to boost search for treatments and cures
tags: 
- companies
author: ft
---

[原文链接](https://ft.com/content/93234331-688c-4fde-823c-c1a8168011b2)

慈善机构设立基金投资脊髓损伤公司

# 摘要：
五家脊髓损伤（SCI）慈善机构合作创建了一个名为 SCI Ventures 的投资工具，旨在支持开发创新治疗方法的公司，帮助因这种病症而残障的人们。该基金以 200 万美元的初始承诺金启动，并计划在今年年底前筹集 4000 万美元资金，重点关注通过药物或基因疗法刺激新脑神经细胞生长的大脑电子设备和生物方法。

## 要点：

1. **SCI Ventures** 是一个新推出的投资工具，最初由五家 SCI 慈善机构承诺提供 270 万美元资金，这些慈善机构来自美国、英国和欧盟。该基金计划在今年年底前筹集高达 4000 万美元资金。

2. 初步投资包括两家为瘫痪患者开发电子设备的公司（Onward Medical 和 Augmental）和两家通过药物或基因疗法追求生物方法的公司（Axonis Therapeutics 和 Sania Therapeutics）。

3. 该基金的成立是**风险慈善**发展的一部分，即医疗慈善机构投资于企业研究，以寻找特定疾病或病症的治疗方法和治愈方法。

4. SCI Ventures 的创始管理总监 Adrien Cohen 强调，最近的科学进步使人们从瘫痪中恢复过来成为可能，但将这些治疗方法转化为临床应用仍然具有挑战性。

5. 该基金将把所有收益重新投资于更多旨在治愈瘫痪的企业，这是一种越来越受欢迎的慈善模式，例如阿尔茨海默病药物发现基金会（Alzheimer's Drug Discovery Foundation）。

---

 **Article Summary:** 
Five spinal cord injury (SCI) charities have collaborated to create an investment vehicle called SCI Ventures with the aim of supporting companies developing innovative treatments for people disabled by this condition. The fund has started with $2amoin in commitments and aims to raise $40mn by year-end, focusing on electronic devices and biological approaches to stimulate new brain and nerve cells growth through drugs or gene therapy.

**Key Points:**
1. **SCI Ventures** is the newly launched investment vehicle with an initial commitment of $27mn from five SCI charities based in the US, UK, and EU. The fund aims to raise up to $40mn by year-end.
2. Initial investments include two companies developing electronic devices for paralysed patients (Onward Medical and Augmental) and two others pursuing biological approaches through drugs or gene therapy (Axonis Therapeutics and Sania Therapeutics).
3. The fund's creation is part of the growth in **venture philanthropy**, where medical charities invest in corporate research to find treatments and cures for specific diseases or conditions.
4. Adrien Cohen, founding managing director of SCI Ventures, highlighted that recent scientific advancements have made recovery from paralysis a real possibility but transferring these treatments to clinical settings remains challenging.
5. The fund will reinvest all gains into more companies aiming to cure paralysis and follows an increasingly popular model for charities, such as the Alzheimer's Drug Discovery Foundation.

[Source Link](https://ft.com/content/93234331-688c-4fde-823c-c1a8168011b2)

